Common Equity: The sum of all common equity items.
NanoViricides, Inc. (NNVC) had Common Equity of $11.46M for the most recently reported fiscal quarter, ending 2024-06-30.
Income Statement Financials | |
-- |
|
$-2.36M |
|
-- |
|
-- |
|
$2.39M |
|
$-2.39M |
|
$0.04M |
|
$-2.36M |
|
$-2.36M |
|
$-2.36M |
|
$-2.36M |
|
$-2.36M |
|
$-2.36M |
|
$-2.39M |
|
$-2.20M |
|
11.87M |
|
11.87M |
|
$-0.19 |
|
$-0.19 |
|
Balance Sheet Financials | |
$4.97M |
|
$7.51M |
|
$7.85M |
|
$12.82M |
|
$1.36M |
|
-- |
|
-- |
|
$1.36M |
|
Common Equity |
$11.46M |
$11.14M |
|
$11.46M |
|
13.14M |
|
Cash Flow Statement Financials | |
$-6.32M |
|
$-0.16M |
|
$3.12M |
|
$8.15M |
|
$4.80M |
|
$-3.35M |
|
$0.22M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
3.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-20.55% |
|
-21.15% |
|
-18.37% |
|
-20.55% |
|
$0.87 |
|
$-0.55 |
|
$-0.53 |